Diagnosis and Treatment of Pulmonary Hypertension : From Bench to Bedside

This book focuses on pulmonary arterial hypertension (PAH, Group 1) and chronic thromboembolic pulmonary hypertension (CTEPH, Group 4) among the various groups of pulmonary hypertension (PH) whose classification was updated into five major categories at the 5th World Symposium held in Nice, France,...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Fukumoto, Yoshihiro. (Editor)
Format: eBook
Language: English
Published: Singapore : Springer Singapore : Imprint: Springer, 2017.
Subjects:
ISBN: 9789812878403
Physical Description: VIII, 236 p. 70 illus., 45 illus. in color. online resource.

Cover

Table of contents

LEADER 03256nam a22003855i 4500
001 100972
003 CZ-ZlUTB
005 20240914113129.0
006 m o d
007 cr nn 008mamaa
008 170105s2017 si | s |||| 0|eng d
020 |a 9789812878403 
024 7 |a 10.1007/978-981-287-840-3  |2 doi 
245 1 0 |a Diagnosis and Treatment of Pulmonary Hypertension :  |b From Bench to Bedside /  |c edited by Yoshihiro Fukumoto. 
264 1 |a Singapore :  |b Springer Singapore :  |b Imprint: Springer,  |c 2017. 
300 |a VIII, 236 p. 70 illus., 45 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a počítač  |b c  |2 rdamedia 
338 |a online zdroj  |b cr  |2 rdacarrier 
505 0 |a Part I Fundamentals of Pulmonary Hypertension -- 1.Clinical Classification -- 2.Diagnosis - Imagings -- Part II Pathophysiology and Genetics -- 3.Pathogenic and Therapeutic Role of MicroRNA in Pulmonary Arterial Hypertension -- 4.Sex Hormones -- 5.Rho-Kinase -- 6.The Unique Property of the Pulmonary Artery Regard-ing the Smooth Muscle Effects of Proteinase-activated Receptor 1 - The Possible Contribution to the Pathogenesis of Pulmonary Hypertension -- 7. Animal Models with Pulmonary Hypertension -- 8.Human Pathology -- 9. Pathophysiology and Genetics: BMPR2 -- Part III Treatment of Pulmonary Arterial Hypertension (PAH) -- 10. Prostacyclin -- 11. Targeting the NO-sGC-cGMP pathway in pulmonary arterial hypertension -- 12. Endothelin Receptor Antagonist -- 13. LUNG TRANSPLANTATION -- Part IV Treatment of Chronic Thromboembolic Pulmonary Hypertension (CTEPH) -- 14. Medical Therapy for Chronic Thromboembolic Pulmonary Hypertension -- 15. Balloon Pulmonary Angioplasty -- 16. Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension -- Part V Right Ventricular Function -- 17. Right Ventricular Function. 
506 |a Plný text je dostupný pouze z IP adres počítačů Univerzity Tomáše Bati ve Zlíně nebo vzdáleným přístupem pro zaměstnance a studenty 
520 |a This book focuses on pulmonary arterial hypertension (PAH, Group 1) and chronic thromboembolic pulmonary hypertension (CTEPH, Group 4) among the various groups of pulmonary hypertension (PH) whose classification was updated into five major categories at the 5th World Symposium held in Nice, France, in 2013. Readers will find recent progress, methods, and up-to-date information on PH mechanisms, diagnostic images, and treatment in the management of PH. This volume, with contributions by leading researchers worldwide in the field , consists of five parts, starting with the fundamentals of PH, then pathophysiology and genetics, treatment, and right ventricular function. 
650 0 |a Medicine. 
650 0 |a Cardiology. 
650 0 |a Respiratory organs  |x Diseases. 
650 0 |a Cardiac surgery. 
655 7 |a elektronické knihy  |7 fd186907  |2 czenas 
655 9 |a electronic books  |2 eczenas 
700 1 |a Fukumoto, Yoshihiro.  |e editor. 
710 2 |a SpringerLink (Online service) 
776 0 8 |i Printed edition:  |z 9789812878397 
856 4 0 |u https://proxy.k.utb.cz/login?url=http://dx.doi.org/10.1007/978-981-287-840-3  |y Plný text 
992 |c NTK-SpringerMED 
999 |c 100972  |d 100972 
993 |x NEPOSILAT  |y EIZ